Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE

Surgeon Scientist, Professor, Brain Tumor Surgeon, NIH and DOD Funded, #TwinMum, #AIMBE, #ASCI @MDAndersonNews, #Nanomedicine, #immunotherapy. Views are my own

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Highlight of my career.
James Allison ⁦@NobelPrize⁩ Medicine 2018,
Phil Sharp ⁦@NobelPrize⁩ Medicine 1983,
Carolyn Bertozzi ⁦@NobelPrize⁩ Chemistry 2022, ⁦@PamSharmaMDPhD⁩ #Mentor. #Inspiring. ⁦@MDAndersonNews⁩ #oncsurgery

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Honored to present @MDAndersonNews James Allison Institute with 5 @NobelPrize (James Allison, Carolyn Bertozzi, Fred Ramsdell, Gary Ruvkun, Phil Sharp) with all-stars Antoni Ribas, Elaine Mardis, Nina Bhardwaj, Cathy Wu, Andrea Shietinger, Marcia Haigis, Wen Jiang, Pam Sharma.

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

First month of kindergarten
I cannot believe they were the size of ⁦@MiffyOfficialUS⁩
#blessed

[UT MD Anderson @UTMDAnderson]

Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research.

We thank the Sabin Family Fellowship for their continued support. https://t.co/R34wV1rtQi
#EndCancer

[OncoDaily IO @OncoDailyIO]

I’ve Joined @MDAndersonNews as an Assistant Professor and Physician-Scientist in Radiation Oncology - @BenjaminSchrank
@BettyKimLab @ACKoongMDPhD

https://t.co/joh6ft6GeD

#RadiationOncology #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews #Immunotherapy #ImmuneOnc

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

@ACKoongMDPhD @PrajnanDasMD @MDAndersonNews Congrats well deserved @PrajnanDasMD!

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

@MDA_UTHGrad So very proud of everyone especially @AnnetteWu9 who was just awarded the best oral presentation. Excited to see what you accomplish Annette @MDAndersonNews. #AStarIsBorn

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Happy Father’s Day to the #BestDad in the world.

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Excited to moderate #GRC First Day Gordon Research Conference and our Airport Shuttle bus experienced slight technical issues…2 hours later almost had to hitchhike our way to #Tuscany. Looking forward to what this week will bring. #CancerNanomedicine

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

As we graduate our extraordinary fellows and residents, I am reminded of how little I knew when I thought I knew. From Highschool to Fellowship-Trained Neurosurgeon Scientist: 26 years.Thank you Mom, Dad, Wen, Hannah, teachers/mentors and our patients.

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Thanks so much Kate for sharing all of your dolls with us! The collection is now complete with #Ariel and #Rapunzel ⁦@American_Girl⁩ ⁦@Disney⁩

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Partners today for #ACLS
Saving lives with ⁦@BenjaminSchrank⁩
⁦@MDAndersonNews⁩

[Kristin Huntoon @KristinHuntoon]

So grateful for our team and looking forward to what more we can accomplished. Check out our newest manuscript how we target the #STING pathway by #microbubbles and #ultrasound
@lux_jacques @BettyKimLab
@YWangPhD @UAZNeurosurgery
https://t.co/OlhMOk6UH8

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

@timheff5 @LabGenovese @MDAndersonNews Congrats @LabGenovese! Great study. Check it out everyone!

[OncoDaily @oncodaily]

Why do tumors evade immune detection, even when phagocytosed? - @BenjaminSchrank
@BettyKimLab @MDAndersonNews @YWangPhD @DYLee_BME @AnnetteWu9

https://t.co/SHLU87264i

#Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

[OncoDaily @oncodaily]

The University of Texas MD Anderson Cancer Center researchers develop novel antibody-toxin conjugate
@MDAndersonNews @BenjaminSchrank @BettyKimLab

Researchers at The University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) designed to stimulate immune-mediated eradication of tumors. 🧬
According to preclinical results published today in Nature Cancer, the new approach combined the benefits of more well-known antibody-drug conjugates (ADCs) with those of immunotherapies💊

https://t.co/TDqd0q4WLb

#Cancer #CancerResearch #CancerTreatment #MedEd #MedNews #MedX #Medicine #Health #Oncology #OncoDaily

[OncoDaily @oncodaily]

@BenjaminSchrank @NatureCancer @BettyKimLab @wenjiang_nano We would like to inform you that your post has been published on https://t.co/igx4msE1Ge. Thank you for sharing such valuable content.
https://t.co/SHLU872DTQ

[Betty Y.S. Kim, MD, PhD, FRCSC, FAIMBE @BettyKimLab]

Buckeroo breakfast with Daddy today. #NowWeAre5

[UT MD Anderson @UTMDAnderson]

MD Anderson researchers have developed a novel antibody toxin-conjugate that’s not designed to kill the cancer cells directly.

Read how this new approach is designed to trigger the body's natural immune response instead: https://t.co/GPkg7AoAP6 #EndCancer